Zymeworks Inc. announced that it has opened a 10,000 square foot laboratory facility in Vancouver, Canada. The new lab will provide Zymeworks with increased control over discovery research, antibody generation, medicinal chemistry and bioconjugation for generating antibody drug conjugates, and the development of multi-functional proteins. Having Zymeworks’ discovery components together in one centralized location will enhance Zymeworks’ ability to expedite certain processes on an as-needed basis.